Mo1935 - Oral Freeze-Dried Fecal Microbiota Capsule Treatment is Effective for Recurrent and Refractory C. Difficile Infection

Dan Joseph Stein; Karen Harrington; Hasan Bader; Sheila Thierfelder; Andrés Yarur; Amir C. Patel; Poonam Beniwal‐Patel; Caroline S. Fox; Steven Visuri

doi:10.1016/s0016-5085(18)32899-3

Article2024

Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation

Baoyi Li, Menghang Zu, Aodi Jiang, Yingui Cao, Jiaxue Wu, Mohammad‐Ali Shahbazi, Xiaoxiao Shi, Rui L Reis, Subhas C. Kundu, Bo Xiao

Article2005

The Combination of Bortezomib, Melphalan, Dexamethasone and Intermittent Thalidomide (VMDT) Is an Effective Treatment for Relapsed/Refractory Myeloma: Results of a Phase II Clinical Trial.

Evangelos Terpos, Αchilles Anagnostopoulos, Efstathios Kastritis, Athanasios Zomas, Christos Poziopoulos, Nikolaos Anagnostopoulos, Konstantinos Tsionos, Meletios A Dimopoulos

Article2020

Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy

Ming Miao, X Jing, De Clercq Erik, Li G

Article2024

Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia

Franca Raucci, Claudio Vernieri, Maira Di Tano, Francesca Ligorio, Olga Blaževitš, Samuel Lazzeri, Anastasiya Shmahala, Giuseppe Fragale, Giulia Salvadori, Gabriele Varano, Stefano Casola, Roberta Buono, Euplio Visco, Filippo de Braud, Valter D. Longo

Preprint2024

Data from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia